A critical role for PKC zeta in endothelin-1-induced uterine contractions at the end of pregnancy.
We have previously shown that protein kinase C (PKC) zeta and/or PKC delta are necessary for endothelin-1 (ET-1)-induced human myometrial contraction at the end of pregnancy (Eude I, Paris P, Cabrol D, Ferré F, and Breuiller-Fouché M. Biol Reprod 63: 1567-1573, 2000). Here, we report that the selective inhibitor of PKC delta isoform, Rottlerin, does not prevent ET-1-induced contractions, whereas LY-294002, a phosphatidylinositol (PI) 3-kinase inhibitor, affects the contractile response. This study characterized the in vitro contractile response of cultured human pregnant myometrial cells to ET-1 known to induce in vitro contractions of intact uterine smooth muscle strips. Cultured myometrial cells incorporated into collagen lattices have the capacity to reduce the size of these lattices, referred to as lattice contraction. Neither the selective conventional PKC isoform inhibitor, Gö-6976, or rottlerin affected myometrial cell-mediated gel contraction by ET-1, whereas this effect was blocked by LY-294002. We found that treatment of myometrial cell lattices with an inhibitory peptide specific for PKC zeta or with an antisense against PKC zeta resulted in a significant loss of ET-1-induced contraction. Evidence is also presented by using confocal microscopy that ET-1 induced translocation of PKC zeta to a structure coincident with the actin-rich microfilaments of the cytoskeleton. We have shown that PKC zeta has a role in the actin organization in ET-1-stimulated cells. Accordingly, our results suggest that PKC zeta plays a role in myometrial contraction in pregnant women.
Institut National de la Santé et de la Recherche Médicale U361, Pavillon Baudelocque, 75014 Paris, France.
G
G
Di Liberto
E
E
Dallot
I
I
Eude-Le Parco
D
D
Cabrol
F
F
Ferré
M
M
Breuiller-Fouché
D008841:Actin Cytoskeleton / Q000201:enzymology; D000906:Antibodies; D003094:Collagen / Q000378:metabolism; D019332:Endothelin-1 / Q000494:pharmacology*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D066298:In Vitro Techniques; D009215:Myometrium / Q000201:enzymology*; D036801:Parturition / Q000378:metabolism; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism*; D051745:Protein Kinase C-delta; D014590:Uterine Contraction / Q000187:drug effects* / Q000378:metabolism*; D000099221:Protein Kinase C zeta
D000906:Antibodies; D003094:Collagen; D019332:Endothelin-1; D011493:Protein Kinase C; D051745:Protein Kinase C-delta; D000099221:Protein Kinase C zeta; C497258:PRKCD protein, human